Expression of CD44 isoforms in renal cell tumors: Positive correlation to tumor differentiation

American Journal of Pathology

Volumn 148, Issue 2, 1996, Pages 453-463

  Terpe, Hans Joachim ^a,b   Störkel, Stephan ^b   Zimmer, Ulrike ^a   Anquez, Viviane ^c   Fischer, Claus ^a   Pantel, Klaus ^d   Günthert, Ursula ^c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; HERMES ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CHROMOPHOBE ADENOMA; CLEAR CELL CARCINOMA; CONTROLLED STUDY; FETUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; ONCOCYTOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR GROWTH;

ADENOCARCINOMA, CLEAR CELL; ADULT; ALKALINE PHOSPHATASE; ALTERNATIVE SPLICING; ANTIGENS, CD44; BASE SEQUENCE; BLOTTING, SOUTHERN; CELL DIFFERENTIATION; EXONS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY; KIDNEY NEOPLASMS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PREGNANCY; RETROSPECTIVE STUDIES; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0030065032     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. American Cancer Society Cancer Facts and Figures, 1994. Atlanta, American Cancer Society, 1994
2. Thoenes W, Störkel S, Rumpelt HJ: Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). Pathol Res Pract 1986, 181. 125-143
3. Gerharz CD, Moll R, Störkel S, Ramp U, Thoenes W, Gabbert HE: Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic and chromophobe types of the human renal cell carcinoma in vitro. Am J Pathol 1993, 142.851-859
4. Storkel S: Phenotypic characteristics and prognostic features Veroeff Pathol 1993, 140.1-165
5. Kovacs G Molecular differential pathology of renal cell tumours. Histopathology 1993, 22:1-8
6. van den Berg E, van der Hout AH, Oosterhuis JW, Störkel S, Dijkhuizen T, Dam A, Zweers HMM, Mensink HJA, Buys CHCM, de Jong B: Cytogenetic analysis of epithelial renal cell tumors: relationship with a new histopathological classification Int J Cancer 1993, 55. 223-227
7. Strohmeyer TQ, Slamon DJ: Proto-oncogenes and tumor suppressor genes in human urological malignancies J Urol 1994, 151:1479-1497
8. Kovacs G Molecular cytogenetics of renal cell tumors Adv Cancer Res 1993, 62.89-124
9. Lubinski J, Hadaczek P, Podolski J, Toloczko A, Sikorski A, McCue P, Druck T, Huebner K. Common regions of deletion in chromosome regions 3p12 and 3p14 2 in primary clear cell renal carcinomas. Cancer Res 1994, 54 3710-3713
10. Kovacs G. The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours World J Urol 1994, 12:64-68
11. Uchida T, Wada C, Wang C, Egawa S, Ohtani H, Koshiba K Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma. Cancer Res 1994, 54:3682-3685
12. Rotter M, Block T, Busch R, Thanner S, Höfler H Expression of HER-2/neu in renal cell carcinoma. Correlation with histologic subtypes and differentiation. Int J Cancer 1992, 9 213-217
13. Droz D, Patey N, Paraf F, Chretien Y, Gogusev J: Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors Lab Invest 1994, 71 710-718
14. Terpe H-J, Zimmer U, Fischer C, Störkel S: Distribution and role of adhesion molecules in renal tumors. J Urol Pathol 1995, 3:37-49
15. Günthert U, Stauder R, Mayer B, Terpe H-J, Finke L, Friedrichs K: Are CD44 variant isoforms involved in human tumour progression? Cancer Surv 1995, 24 19-42
16. Ruiz P, Schwärzler C, Günthert U. CD44 isoforms during differentiation and development BioEssays 1995, 17:17-24
17. Screaton GR, Bell MV, Bell JI, Jackson DG: The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem 1993, 268.12235-12238
18. Günthert U CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 1993, 184. 47-63
19. Günthert U Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers motastatic potential to rat carcinoma cells. Cell 1991, 65:13-24
20. Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzku S, Zöller M: Prevention of tumor metastasis formation by anti-variant CD44 J Exp Med 1993, 177:443-455
21. Terpe H-J, Stark H, Prehm P, Gunthert U: CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues Histochemistry 1994, 101:79-89
22. Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A, Simmons DL: Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 1994, 54:4539-4546
23. Terpe HJ, Tajrobehkar K, Günthert U, Altmannsberger M Expression of cell adhesion molecules alpha-2, alpha-5 and alpha-6 integrin, E-cadherin, N-CAM and CD-44 in renal cell carcinomas. An immunohistochemical study. Virchows Arch A (Pathol Anat Histopathol) 1993, 422:219-224
24. Mostofi FK (ed.): Histological typing of kidney tumours International Histologic Classification of Tumours, no 25. Geneva, World Health Organization, 1981
25. Thoenes W, Störkel S, Rumpelt H-J, Moll R, Baum HP, Werner S: Chromophobe cell renal carcinoma and its variants, a report on 32 cases J Pathol 1988, 155.277-287
26. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994, 124 71-82
27. Dall P, Heider K-H, Sinn H-P, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H: Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer Int J Cancer 1995, 60:471-477
28. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KF, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP-complexes). J Histochem Cytochem 1984, 32:219-229
29. Stauder R, Eisterer W, Thaler J, Günthert U: CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor Blood 1995, 85 2885-2899
30. Chomczynski P, Sacchi N A single-step method of RNA isolation by acid guanidmium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
31. Stauder R, Günthert U CD44 isoforms: impact on lymphocyte activation and differentiation. Immunologist 1995, 3 26-31
32. van der Poel HG, Mulders PF, Oosterhof GO, Schaafsma HE, Hendriks JC, Schalken JA, Debruyne FM: Prognostic value of karyometric and clinical characteristics in renal cell carcinoma Quantitative assessment of tumor heterogeneity Cancer 1993, 72 2667-2674
33. Storkel S, Keymer R, Steinbach F, Thoenes W Reaction patterns of tumor infiltrating lymphocytes in different renal cell carcinomas and oncocytomas. Prog Clin Biol Res 1992, 378 217-223
34. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N: Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 1995, 128:673-685
35. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A. CD44 isoforrns containing exon v3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995, 128:687-698
36. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease Nature Med 1995, 1:27-31
37. Fujimoto K, Ichimori Y, Kakizoe T, Okajima E, Sakamoto H, Sugimura T, Terada M Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem Biophys Res Commun 1991, 180. 386-392
38. Nanus DM, Schmitz-Drager BJ, Motzer RJ, Lee AC, Vlamis V, Cordon-Cardo C, Albino AP, Reuter VE. Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J Natl Cancer Inst 1993, 85.1597-1599
39. Kovacs A, Störkel S, Thoenes W, Kovacs G Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas. J Pathol 1992, 167: 273-277
40. Pantel K, Schlimok G, Braun S, Kutter D, Lindemann F, Schaller G, Funke I, Izbicki JR, Riethmüller G. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 1993, 85:1419-1424